/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

K

Ken Inada

Tokyo Women's Medical University(JP)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

165

Papers

1.6K

Citations

23

h-index

56

i10-index

Ken Inada is an academic researcher from Tokyo Women's Medical University. The author has contributed to research in topics: Schizophrenia research and treatment & Treatment of Major Depression & Sleep and related disorders. The author has an h-index of 23, co-authored 141 publications.

ORCID: 0000-0002-3073-4588

Research Topics

Schizophrenia research and treatment Treatment of Major Depression Sleep and related disorders Bipolar Disorder and Treatment Neuroscience and Neuropharmacology Research

Papers by this author

works

Toward recovery in schizophrenia: Current concepts, findings, and future research directions

2022 · Psychiatry and Clinical Neurosciences · 62 citations

https://doi.org/10.1111/pcn.13342

Toshiaki Onitsuka Yoji Hirano Takanobu Nakazawa Kayo Ichihashi

Improvement of psychiatrists’ clinical knowledge of the treatment guidelines for schizophrenia and major depressive disorders using the ‘Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)’ project: A nationwide dissemination, education, and evaluation study

2019 · Psychiatry and Clinical Neurosciences · 50 citations

https://doi.org/10.1111/pcn.12911

Yoshikazu Takaesu Koichiro Watanabe Shusuke Numata Masaaki Iwata

Characteristics of discharge prescriptions for patients with schizophrenia or major depressive disorder: Real-world evidence from the Effectiveness of Guidelines for Dissemination and Education (EGUIDE) psychiatric treatment project

2021 · Asian Journal of Psychiatry · 40 citations

https://doi.org/10.1016/j.ajp.2021.102744

Naoki Hashimoto Norio Yasui‐Furukori Naomi Hasegawa Shuhei Ishikawa

Hypnotic medication use among inpatients with schizophrenia and major depressive disorder: results of a nationwide study

2021 · Sleep Medicine · 29 citations

https://doi.org/10.1016/j.sleep.2021.11.005

Ryuji Furihata Rei Otsuki Naomi Hasegawa Takashi Tsuboi

Improvements in the degree of understanding the treatment guidelines for schizophrenia and major depressive disorder in a nationwide dissemination and implementation study

2021 · Neuropsychopharmacology Reports · 22 citations

https://doi.org/10.1002/npr2.12173

Shusuke Numata Masahito Nakataki Naomi Hasegawa Yoshikazu Takaesu

The characteristics of patients receiving psychotropic pro re nata medication at discharge for the treatment of schizophrenia and major depressive disorder: A nationwide survey from the EGUIDE project

2022 · Asian Journal of Psychiatry · 16 citations

https://doi.org/10.1016/j.ajp.2022.103007

Kayo Ichihashi Yoshitaka Kyou Naomi Hasegawa Norio Yasui‐Furukori

Research topics

topics

Schizophrenia research and treatment

Treatment of Major Depression

Sleep and related disorders

Bipolar Disorder and Treatment

Neuroscience and Neuropharmacology Research

Chat about Author

Papers

Chat

Click to start Chat